PharmaEngine Financial Flexibility Index
PharmaEngine financial flexibility index. PharmaEngine (4162) has a Financial Flexibility Index of 0.47x as of September 2025. Free cash flow of NT$53.12 Million (operating CF NT$53.01 Million minus capex NT$115.00K) represents 0% of total liabilities (NT$112.86 Million). See PharmaEngine free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PharmaEngine (2009–2024)
Financial flexibility index of PharmaEngine from 2009 to 2024. Historical Financial Flexibility Index trend for PharmaEngine across 16 annual periods. Check 4162 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
PharmaEngine Financial Flexibility Index by Year (2009–2024)
PharmaEngine financial flexibility index by year from 2009 to 2024. Year-by-year free cash flow to debt coverage for PharmaEngine. For the full cash flow conversion analysis, see PharmaEngine operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.02x | NT$458.15 Million | NT$456.73 Million | NT$448.01 Million | ▼ -63.9% |
| 2023 | 2.83x | NT$257.93 Million | NT$256.97 Million | NT$91.01 Million | ▲ +30.0% |
| 2022 | 2.18x | NT$205.96 Million | NT$202.01 Million | NT$94.47 Million | ▼ -79.4% |
| 2021 | 10.60x | NT$929.90 Million | NT$929.67 Million | NT$87.70 Million | ▲ +3075.0% |
| 2020 | 0.33x | NT$65.38 Million | NT$64.77 Million | NT$195.78 Million | ▲ +228.9% |
| 2019 | 0.10x | NT$16.29 Million | NT$16.08 Million | NT$160.40 Million | ▼ -97.9% |
| 2018 | 4.88x | NT$745.74 Million | NT$745.23 Million | NT$152.67 Million | ▲ +388.2% |
| 2017 | -1.69x | NT$-338.81 Million | NT$-339.30 Million | NT$199.90 Million | ▼ -131.2% |
| 2016 | 5.43x | NT$871.53 Million | NT$870.38 Million | NT$160.48 Million | ▼ -6.2% |
| 2015 | 5.79x | NT$459.80 Million | NT$447.99 Million | NT$79.41 Million | ▼ -20.5% |
| 2014 | 7.28x | NT$131.18 Million | NT$131.09 Million | NT$18.02 Million | ▲ +498.1% |
| 2013 | -1.83x | NT$-47.37 Million | NT$-47.37 Million | NT$25.90 Million | ▼ -137.8% |
| 2012 | 4.84x | NT$68.73 Million | NT$68.64 Million | NT$14.20 Million | ▼ -72.7% |
| 2011 | 17.72x | NT$276.29 Million | NT$275.49 Million | NT$15.59 Million | ▲ +530.9% |
| 2010 | -4.11x | NT$-56.95 Million | NT$-57.26 Million | NT$13.85 Million | ▼ -38.9% |
| 2009 | -2.96x | NT$-90.33 Million | NT$-90.54 Million | NT$30.50 Million | — |